Brian Wodzisz

Brian Wodzisz serves as a primary contracting professional within the Food and Drug Administration, supporting the agency’s mission to ensure the safety and efficacy of regulated products through strategic procurement of advanced scientific and technical services. He manages a diverse portfolio of acquisitions focused on analytical instrumentation, laboratory automation, digital diagnostics, and specialized IT solutions that enable evidence-based regulatory decision-making. His work directly supports the FDA’s modernization initiatives, ensuring that scientific evaluation capabilities keep pace with emerging technologies in pharmaceuticals, medical devices, and food safety analytics. Wodzisz maintains longstanding partnerships with leading federal contractors including Peraton Enterprise Solutions LLC, Deloitte Consulting LLP, and Booz Allen Hamilton Inc., who provide mission-critical support in systems integration, data analytics, and regulatory technology development. He also collaborates with specialized firms such as MPF-ZAI Solutions LLC and Harvard Pilgrim Health Care Inc. to deliver niche expertise in health informatics and clinical data evaluation. His contracting patterns reflect a preference for established contractors with proven capabilities in high-complexity, high-compliance environments, while maintaining flexibility to engage innovative vendors for agile solutions. His procurement approach prioritizes open competition, with 73.1% of acquisitions issued without set-aside restrictions, yet he consistently integrates small business opportunities, particularly through Total Small Business Set-Asides under FAR 19.5 (23.1%) and Service-Disabled Veteran-Owned Small Business Set-Asides (3.9%). This balanced strategy ensures broad market access while maintaining the technical rigor required for FDA’s high-stakes regulatory missions. Wodzisz’s primary NAICS focus includes Other Computer Related Services (541519), Analytical Laboratory Instrument Manufacturing (334516), and Custom Computer Programming Services (541511), reflecting deep engagement with laboratory informatics, instrument procurement, and bespoke software development for regulatory workflows. His expertise spans the integration of next-generation analytical platforms, diagnostic algorithms, and data management systems essential to the FDA’s scientific infrastructure.